Andrew Callos, EVP, Chief Commercial Officer: Cytokinetics CYTK Sell · Filed 03/18

Trade details

Type: Insider sale
Amount: $349,655.9
Shares · price: 5,626 sh · $62.15 a share
Held after: 74,489 sh
Stock: Cytokinetics CYTK
Person: Andrew CallosEVP, Chief Commercial Officer
Trade date: 26/03/17
Filed: 26/03/18
Days to filing: 1 days

Sold 7.0% of holdings

Share of holding sold: 7.0%

Cytokinetics trades, last 26 weeks

What else happened in Cytokinetics around then

Filed or reported within 30 days of the trade day · 02/15~04/16

Andrew Callos's recent trades

Andrew CallosEVP, Chief Commercial Officer
Planned sale10b5-1 planCytokinetics
Planned sale10b5-1 plan
Cytokinetics
CYTK
$1.9M
24,000 sh
$1.9M
Filed 07/30
Traded 07/30
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$1.1M
15,000 sh
$1.1M
Filed 06/01
Traded 06/01
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$875.5K
11,333 sh
$875.5K
Filed 05/05
Traded 05/05
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$1M
15,857 sh
$1M
Filed 05/04
Traded 05/01
Andrew CallosEVP, Chief Commercial Officer
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$948.9K
15,000 sh
$948.9K
Filed 04/30
Traded 04/30

Andrew Callos, Chief Officer — sold $349.7K of Cytokinetics CYTK · 7.0% of holdings | Whalegun